H L McLeod|M V Relling - JoVE Visualize

Showing results (161-170 of 281) with videos related to

Pageof 29

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996

Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemiaM V Relling, H H Mahmoud, C H Pui, et al.

British Journal of Cancer|January 19, 2005

Unfavourable expression of pharmacologic markers in mucinous colorectal cancerS C Glasgow, J Yu, L P Carvalho, et al.

British Journal of Cancer|February 13, 2001

Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034D Bissett, H L McLeod, B Sheedy, et al.

Genomics|August 29, 1998

Characterization of the human dihydropyrimidine dehydrogenase geneX Wei, G Elizondo, A Sapone, et al.

Cancer|September 1, 1988

Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusionM V Relling, F B Stapleton, J Ochs, et al.

Internal Medicine (Tokyo, Japan)|January 11, 2000

Thiopurine methyltransferase genotype and the toxicity of azathioprine in JapaneseS Ishioka, K Hiyama, H Sato, et al.

Biochemical Pharmacology|June 8, 2001

Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistanceM C McFadyen, H L McLeod, F C Jackson, et al.

Blood Cancer Journal|February 18, 2017

The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemiaH M Eissa, Y Zhou, J C Panetta, et al.

Clinical Pharmacokinetics|March 1, 1987

Pharmacokinetics of anticancer drugs in childrenW R Crom, A M Glynn-Barnhart, J H Rodman, et al.

Molecular Pharmacology|July 1, 1997

Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicityA J Galpin, J D Schuetz, E Masson, et al.

Pageof 29

Showing results (161-170 of 281) with videos related to

Sort By:

Pageof 29

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996

Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemiaM V Relling, H H Mahmoud, C H Pui, et al.

British Journal of Cancer|January 19, 2005

Unfavourable expression of pharmacologic markers in mucinous colorectal cancerS C Glasgow, J Yu, L P Carvalho, et al.

British Journal of Cancer|February 13, 2001

Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034D Bissett, H L McLeod, B Sheedy, et al.

Genomics|August 29, 1998

Characterization of the human dihydropyrimidine dehydrogenase geneX Wei, G Elizondo, A Sapone, et al.

Cancer|September 1, 1988

Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusionM V Relling, F B Stapleton, J Ochs, et al.

Internal Medicine (Tokyo, Japan)|January 11, 2000

Thiopurine methyltransferase genotype and the toxicity of azathioprine in JapaneseS Ishioka, K Hiyama, H Sato, et al.

Biochemical Pharmacology|June 8, 2001

Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistanceM C McFadyen, H L McLeod, F C Jackson, et al.

Blood Cancer Journal|February 18, 2017

The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemiaH M Eissa, Y Zhou, J C Panetta, et al.

Clinical Pharmacokinetics|March 1, 1987

Pharmacokinetics of anticancer drugs in childrenW R Crom, A M Glynn-Barnhart, J H Rodman, et al.

Molecular Pharmacology|July 1, 1997

Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicityA J Galpin, J D Schuetz, E Masson, et al.

Pageof 29